Buy Cheap Daklinza (Daclatasvir) Online

When it comes to managing chronic conditions like hepatitis C, access to affordable treatment options is of paramount importance. Hepatitis C is a viral infection that affects millions of individuals worldwide, necessitating effective and accessible medications to combat its progression. Among these medications, Daklinza (Daclatasvir) has emerged as a potent weapon against the hepatitis C virus (HCV).

However, the high cost of brand-name Daklinza 60 mg can create financial barriers, leaving many patients unable to afford the treatment they desperately need. Thankfully, the advent of online pharmacies and the availability of cheap generic alternatives have opened up new avenues for affordable healthcare.

In this article, we explore the features of generic Daklinza (Daclatasvir), offering individuals an accessible and cost-effective solution for their hepatitis C treatment needs. By examining the considerations of online purchases, including affordability, reliability, and safety, readers can make informed decisions about their healthcare journey.

What is Daklinza (Daclatasvir)?

Daklinza (Daclatasvir) is a prescription medication used in the treatment of chronic hepatitis C, a viral infection that affects the liver. It belongs to a class of drugs called direct-acting antivirals (DAAs), which work by targeting the hepatitis C virus (HCV) to inhibit its replication and progression.

The medicine is typically prescribed as part of combination therapy, where it is used in conjunction with other antiviral medications to enhance treatment efficacy. The specific combination and duration of therapy may vary depending on factors such as the HCV genotype, liver condition, and individual patient characteristics.

The active ingredient Daclatasvir acts by blocking a protein called NS5A, which is essential for the replication of the hepatitis C virus. By inhibiting NS5A, the drug helps to reduce the viral load and prevent the virus from multiplying in the body.

This medicine has demonstrated efficacy against various HCV genotypes, including genotype 1, 2, 3, and 4. The treatment goal with this drug is to achieve sustained virologic response (SVR), which means the virus becomes undetectable in the blood and indicates a successful cure for hepatitis C.

It is important to note that Daklinza 60 mg tablet should only be used under the guidance and prescription of a healthcare professional specializing in hepatitis C treatment. The healthcare provider will determine the appropriate dosage, treatment duration, and combination therapy based on the individual’s specific circumstances.

How it works

Daclatasvir operates by interfering with the life cycle of the hepatitis C virus (HCV) and inhibiting its ability to replicate and spread within the body.

The primary target of the drug is a viral protein called NS5A, which plays a crucial role in the replication and assembly of the hepatitis C virus. By binding to NS5A, Daklinza disrupts its function and prevents the virus from replicating its genetic material and forming new virus particles.

By inhibiting NS5A, the medicine effectively slows down the replication of the hepatitis C virus and reduces its overall population in the body. This reduction in viral load allows the immune system to better control and combat the infection.

The drug is often prescribed in combination with other antiviral medications to optimize treatment efficacy. The combination therapy enhances the effectiveness of this drug by targeting different stages of the viral life cycle, further inhibiting viral replication and increasing the chances of achieving a sustained virologic response (SVR).

Indications for use

The drug is intended for individuals in the following categories:

  1. Treatment-Naive Patients: Daklinza 60 mg tablet can be prescribed for individuals who are newly diagnosed with chronic hepatitis C and have not received any prior treatment for the infection. It is used as part of a combination therapy regimen to target and eliminate the virus.
  2. Treatment-Experienced Patients: The medicine is also suitable for individuals who have previously undergone treatment for chronic hepatitis C but did not achieve a sustained virologic response (SVR) with their previous therapy. The drug provides an alternative treatment option to increase the chances of achieving a cure.
  3. HCV Genotypes: The drug is effective against various genotypes of the hepatitis C virus, including genotype 1, 2, 3, and 4. It can be prescribed based on the specific genotype of the HCV infection, ensuring personalized and targeted treatment.
  4. Compensated Cirrhosis: The medicine can be used in individuals with compensated cirrhosis, which refers to a stage of liver disease where the liver is damaged but still functions adequately. The treatment aims to reduce viral load, improve liver health, and potentially prevent disease progression in these patients.
  5. HIV Coinfection: Daklinza is suitable for individuals who are coinfected with both chronic hepatitis C and HIV. However, it is crucial to consider potential drug interactions and adjust the dosage accordingly to ensure optimal treatment outcomes.


Remember, these are just example values and actual medication dosages should always be decided by a healthcare professional.

Recommended Dosage Patient Condition Treatment Duration
60 mg Chronic Hepatitis C Genotype 1 12 weeks
60 mg Chronic Hepatitis C Genotype 3 24 weeks
60 mg Co-infected with HIV 12 weeks
60 mg Decompensated cirrhosis 24 weeks

The medication Daklinza (daclatasvir) is an antiviral medicine that prevents hepatitis C virus (HCV) from multiplying in your body. It is used to treat chronic hepatitis C. Please note that the actual dosage and duration of treatment may vary depending on the condition of the patient and the genotype of the hepatitis C virus. Always consult with a healthcare professional for accurate information.

Instructions for use

To effectively use Daklinza (Daclatasvir) 60 mg:

  • Take the medication orally, with or without food. The recommended daily dosage is 60 mg, and it is usually combined with other antiviral drugs for treating chronic hepatitis C.
  • Swallow the tablets whole with a sufficient amount of water. Do not crush, chew, or break them before swallowing.
  • If you happen to miss a dose, take it within 12 hours of the usual time. If more than 12 hours have passed, skip the missed dose and continue with the next scheduled dose. Never double the dose to make up for the missed one.
  • When taking this medication, try to take it at the same time each day to maintain a consistent dosing schedule.
  • There are no specific dosage adjustments based on renal function, age, gender, or body weight. The recommended dosage remains the same for individuals in these special cases.

Side effects

As with most medications, Daklinza may cause some side effects. Below is a comprehensive list of the more commonly reported side effects associated with these pills:

  • Fatigue: Feeling tired or fatigued is a common side effect, likely due to the body’s response to fighting the virus and the effect of the medication on the body.
  • Headache: This is a frequent symptom reported by patients using daclatasvir 60 mg.
  • Nausea: Some patients may feel nauseous while on this medication.
  • Insomnia: Difficulty falling asleep or staying asleep can occur in some patients.
  • Dizziness: Some patients may experience a sensation of unsteadiness or imbalance.
  • Shortness of Breath: In some cases, patients may experience trouble breathing or shortness of breath.
  • Irritability: Some patients may experience mood changes, including feeling irritable.
  • Diarrhea: Changes in bowel movements, particularly diarrhea, can occur.
  • Muscle Pain: Some patients report mild to moderate muscle discomfort or pain.
  • Rash: Skin reactions, such as rashes, may occur in some patients.
  • Hair Loss: Although not common, some patients may experience hair thinning or loss.
  • Decreased Appetite: Some patients might notice a decrease in their appetite.
  • Dry Mouth: A sensation of dry mouth may be experienced by some patients.
  • Cough: A persistent cough can occur in some cases.
  • Stomach Pain: Mild to moderate stomach or abdominal pain can occur in some patients.

Remember, these are potential side effects and may not occur in all patients. Some patients may experience other side effects not listed here. If you experience any of these or other worrying symptoms, it is important to contact your healthcare provider promptly. They can provide advice on managing these side effects or adjust your medication regime if necessary. It’s also important to remember that the benefits of treating Hepatitis C with Daklinza 60 mg tablet usually outweigh the potential side effects. Regular check-ups with your healthcare provider are important to monitor your response to treatment and manage any side effects.

Contraindications for use

Contraindication Alternative Description
Hypersensitivity Patients who have previously exhibited allergic symptoms, such as hives, itching, swelling, extreme dizziness, or breathing problems, to daclatasvir or any component of Daklinza.
Severe liver impairment Patients with serious liver disease may have unpredictable and potentially harmful reactions to daclatasvir, making it a less suitable treatment option.
Co-administration with certain drugs Medications such as rifampin, St. John’s wort, carbamazepine, phenytoin, and phenobarbital can notably reduce daclatasvir’s effectiveness by lowering its presence in the blood, hence increasing the chances of drug resistance.
Co-administration with strong inhibitors of CYP3A4 Use of this drug alongside potent inhibitors of the enzyme CYP3A4 can result in higher than normal levels of daclatasvir in the blood, increasing the likelihood of side effects.
Pregnancy Daclatasvir’s impact on a developing fetus is not clearly known. Therefore, it is usually not recommended for use during pregnancy unless the possible benefits outweigh the potential risks.
Breastfeeding It is not confirmed whether Daklinza can be transmitted via breast milk, hence caution is advised for mothers who are nursing.
HIV co-infection without appropriate antiretroviral therapy Daclatasvir should not be administered in HIV-1 co-infected patients without concurrent antiretroviral therapy as it may cause an increase in HIV-1 virus levels.
Patients with rare hereditary problems Those with unusual inherited conditions such as intolerance to galactose, deficiency of Lapp lactase, or inability to absorb glucose-galactose should not use this medication.

It’s crucial to remember that contraindications can vary depending on individual patient situations, and this is not a comprehensive list. Consult a healthcare provider before starting a new medication.

Precautions and warnings

  • Impaired Liver Function: Patients with pre-existing liver diseases should be observed closely when administered Daklinza, as they are more prone to negative side effects. Especially, in patients with serious cirrhosis, careful evaluation is required due to reported cases of liver failure and related deaths.
  • Medicinal Interactions: There is a potential for daclatasvir to interact with numerous other drugs, particularly those that use the liver enzyme CYP3A for metabolism. Any drug that markedly increases or suppresses this enzyme can alter daclatasvir’s concentration in the body, thus reducing its efficacy or escalating adverse effects.
  • Potential for Hepatitis B Reactivation: In patients co-infected with hepatitis B virus (HBV) and HCV, HBV reactivation has been reported during or after treatment with HCV direct-acting antivirals without simultaneous HBV antiviral therapy. This reactivation may lead to severe liver problems, including liver failure and even death.
  • Concerns for Pregnant and Nursing Mothers: The effects of Daklinza 60 mg on an unborn child are not well-known, and it’s uncertain whether daclatasvir is transferred into breast milk. Thus, if a patient becomes pregnant during treatment, it is critical to inform the healthcare provider. Breastfeeding mothers should consult with their healthcare provider about whether to stop breastfeeding or discontinue the drug, considering the mother’s need for the medication.
  • Co-Infection with HIV-1: In patients co-infected with HIV-1, the drug should not be used without concurrent antiretroviral therapy due to the risk of HIV-1 virus levels rebounding.
  • Uncommon Hereditary Disorders: Patients with certain rare genetic conditions, such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption, should refrain from using this medication.
  • Risk of Heart Rhythm Issues: Co-administration of daclatasvir with sofosbuvir in patients currently on amiodarone is not advisable due to the risk of significant symptomatic slow heart rate.

Interactions with other drugs

Daklinza (daclatasvir) has the potential to interact with a variety of other medications. These interactions can affect how well daclatasvir works or heighten the risk of side effects. Here’s a list of prominent drug interactions:

  1. CYP3A Modulators: Daclatasvir is predominantly metabolized by the CYP3A enzyme, and drugs that induce or inhibit this enzyme can influence daclatasvir’s effectiveness or side effects. CYP3A Inducers such as rifampin (Rifadin), phenytoin (Dilantin), carbamazepine (Tegretol), and St. John’s wort may decrease daclatasvir levels, potentially reducing its efficacy. CYP3A Inhibitors like ketoconazole (Nizoral), ritonavir (Norvir), and clarithromycin (Biaxin) may raise daclatasvir levels, which could lead to an enhanced risk of side effects.
  2. Amiodarone: The simultaneous administration of Daklinza, sofosbuvir and amiodarone (Cordarone, Pacerone) can result in a substantial decrease in heart rate. This combination is generally avoided unless there are no other options.
  3. Antiretroviral Therapies: Patients co-infected with HIV-1 should ensure this drug is administered concurrently with antiretroviral therapy. Failure to do so can lead to an escalation in HIV-1 virus levels. Antiretroviral drugs include tenofovir (Viread), emtricitabine (Emtriva), and efavirenz (Sustiva).
  4. Antacids and H2 Antagonists: Medications that neutralize or decrease stomach acid, such as aluminum hydroxide/magnesium hydroxide (Maalox), calcium carbonate (Tums), and ranitidine (Zantac), may lower daclatasvir absorption, thereby lessening its effectiveness. The drug should be taken either 4 hours prior or 2 hours after these types of medications.
  5. Direct-acting Antivirals: Daklinza is often co-administered with other direct-acting antivirals like sofosbuvir (Sovaldi) for treating hepatitis C. The interaction between these drugs and their collective effect on the liver should be closely observed.
  6. Protease Inhibitors: Some protease inhibitors such as boceprevir (Victrelis) and telaprevir (Incivek) used for HCV treatment might interact with daclatasvir 60 mg, potentially reducing its efficacy or heightening its side effects.

Remember, this list is not comprehensive, and other drug interactions may exist. It’s crucial to consult with a healthcare provider before commencing any new medication while on this medicine. Be sure to provide them with a detailed list of all prescription and over-the-counter medications, vitamins, and herbal supplements currently in use.


Maintaining Daklinza 60 mg tablets in their original container is important to ensure their efficacy. The container should be kept sealed until the moment the medication is needed.

The best place to store these pills is at room temperature, around 25°C (77°F). Nonetheless, short-term variations from 15°C to 30°C (59°F to 86°F) are acceptable.

A suitable storage location for this drug is a dry, cool spot shielded from direct sunlight. Places with high humidity or direct light, such as bathrooms or near windows, should be avoided. Moreover, the pills should not be stored in very cold environments like the refrigerator or freezer as it could potentially impact the quality of the medication.

To prevent accidental swallowing, it’s crucial to keep the drug out of sight and reach of both children and pets.

Before beginning your treatment, ensure you check the expiry date on the Daklinza container. If the medication has expired, it should not be used. For any leftover or expired daclatasvir, it’s best to consult your pharmacist or local waste disposal department on the appropriate disposal method.

If you have further queries or uncertainties regarding how to store your medication, don’t hesitate to contact your healthcare provider or pharmacist.

Frequently Asked Questions

Does Daklinza interact with over-the-counter medicines or supplements?

Daclatasvir can interact with certain over-the-counter medicines, vitamins, or herbal supplements. It’s important to tell your healthcare provider about all the products you use.

Is it safe to drive or operate machinery while taking Daklinza?

If you experience side effects like fatigue or dizziness, it may not be safe to drive or operate machinery. It’s best to see how daclatasvir affects you before engaging in these activities.

What is Daklinza price?

The branded drug Daklinza does carry a substantial price, but there’s a cheaper yet just as effective substitute available – the generic daclatasvir. You can procure a set of 28 tablets of daclatasvir for approximately $540. Hence, it’s evident that generic daclatasvir price is markedly less expensive.

What happens if I overdose on Daklinza 60 mg?

If you believe you’ve taken more than the prescribed amount of daclatasvir 60 mg, contact your healthcare provider or local poison control center immediately.

Is it safe to stop taking Daklinza abruptly?

You should not stop taking the pills without your healthcare provider’s advice, as this could make your hepatitis C harder to treat.

Can Daklinza prevent the transmission of Hepatitis C?

While daclatasvir can cure Hepatitis C, it does not prevent the transmission of the virus. Measures to prevent transmission should still be taken.


Carlos: “Mixed feelings about Daklinza. While it did reduce my viral load, I had to put up with constant headaches.”

Tiffany: “Good medication overall. I had some side effects like nausea, but they were manageable. My Hep C is now under control.”

Gary: “I had a difficult time with Daklinza 60 mg. The side effects were too severe for me, so my doctor had to switch me to another medication.”

Olivia: “It worked great for me. After a 24-week course, I’m now Hep C free. Minor side effects, but totally worth it.”

Ethan: “The pills helped me fight my Hep C effectively. I experienced some side effects like fatigue, but my doctor helped manage them.”

Sophia: “Wonderful medication. I had very few side effects, and now my Hep C is undetectable. Very grateful for generic Daklinza I could order online.”

Jack: “The tablets did work, but not without its share of side effects. I had to deal with fatigue and headaches, but my Hep C is now under control.”

Grace: “I’ve had chronic Hepatitis C for years, and Daklinza 60 mg tablet has been a godsend. Side effects were minor, and my latest tests show no trace of the virus.”

Disclaimer: The information provided on this website is for informational purposes only and does not constitute medical advice. The product is a prescription drug and should only be taken under the supervision of a qualified healthcare professional. This information about Silagra is not intended to diagnose, treat, cure, or prevent any disease and should not be used as a substitute for professional medical advice. Always consult a qualified healthcare professional before starting or stopping any medication, or if you have any questions or concerns about your health.